Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases.

about

Changes in T cell effector functions over an 8-year period with TNF antagonists in patients with chronic inflammatory rheumatic diseases.

Item

http://www.wikidata.org/entity/Q55305483

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@en

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@nl

type

Item

label

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@en

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@nl

prefLabel

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@en

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@nl

P1476

Changes in T cell effector fun ...... flammatory rheumatic diseases.

@en

P2093

Fabio Mengoni

http://www.w3.org/2001/XMLSchema#string

Paola Sessa

http://www.w3.org/2001/XMLSchema#string

Rossana Scrivo

http://www.w3.org/2001/XMLSchema#string

Vincenzo Vullo

http://www.w3.org/2001/XMLSchema#string

P2860

The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis

Co-stimulatory members of the TNFR family: keys to effective T-cell immunity?

Treatment of rheumatoid arthritis with etanercept with reference to disease-modifying anti-rheumatic drugs: long-term safety and survival using prospective, observational data.

Mature T lymphocyte apoptosis--immune regulation in a dynamic and unpredictable antigenic environment.

Anti-TNF alpha therapy of rheumatoid arthritis: what have we learned?

Chronic exposure to tumor necrosis factor (TNF) in vitro impairs the activation of T cells through the T cell receptor/CD3 complex; reversal in vivo by anti-TNF antibodies in patients with rheumatoid arthritis.

Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis.

Increased peripheral T cell reactivity to microbial antigens and collagen type II in rheumatoid arthritis after treatment with soluble TNFalpha receptors.

Impaired Th1 cytokine production in spondyloarthropathy is restored by anti-TNFalpha

Inhibition of anti-tuberculosis T-lymphocyte function with tumour necrosis factor antagonists

P2888

s41598-018-26097-x

P304

7881

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-26097-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Guido Valesini

Claudio M. Mastroianni

Ilaria Sauzullo

P577

2018-05-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1103975559

http://www.w3.org/2001/XMLSchema#string

P698

29777119

http://www.w3.org/2001/XMLSchema#string

P921

TNF

P932

5959893

http://www.w3.org/2001/XMLSchema#string